Recent investment activity

KANDO id: 591526

Corporate information

Fund terms

Fund manager
Vintage
2017
Fund type

Funding rounds

Fund Closing GBP 4,550,000


( )
The first Fund Twenty8 closed in 2017 and finished deploying in 2018. Investment from 233 professional clients, each investing between £10,000 and £200,000.


Actual initial investment stage
N/A (32)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 32
Profile Country Date Funding
10to8 Ltd N/A Initial investment GBP 124,124
ALERT Technology The world's first range of portable, accurate real-time warning devices to alert users to the presence of deadling airborne asbestos fibres. N/A Initial investment GBP 153,563
Arcis Biotechnology Holdings Ltd N/A Initial investment GBP 43,953
Articheck N/A Initial investment GBP 154,700
Biotechspert N/A Initial investment GBP 50,273
Brytlyt N/A Initial investment GBP 182,000
Camallergy N/A Initial investment GBP 155,855
Cambridge Nutraceuticals N/A Initial investment GBP 189,872
Celame N/A Initial investment GBP 86,022
Cyance Ltd N/A Initial investment GBP 185,640
Dem DX N/A Initial investment GBP 97,370
Digital Therapeutics N/A Initial investment GBP 46,829
Dymag N/A Initial investment GBP 131,859
Emoquo N/A Initial investment GBP 155,943
Engenie N/A Initial investment GBP 143,325
ePatient Network N/A Initial investment GBP 110,101
Fantoo N/A Initial investment GBP 42,041
Freedom One Life N/A Initial investment led the round GBP 98,517
Make it Social N/A Initial investment led the round GBP 148,962
MBASO Ltd (SupaPass) N/A Initial investment GBP 155,009
Metrion Biosciences Ltd N/A Initial investment GBP 168,350
Momentum Bioscience N/A Initial investment GBP 145,600
Pekama N/A Initial investment GBP 153,654
Peptinnovate N/A Initial investment GBP 153,790
Re-Vana Therapeutics N/A Initial investment GBP 155,077

Current team

Past employees

Selected Products / Customers

Financials